1 completed, 1 recruiting, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Chemoradiotherapy: new trials by email Literature Review of Chemoradiotherapy trials Research Report on Chemoradiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemoradiotherapy in Unresectable Esophageal Cancer Radiotherapy, Albumin-Bound Paclitaxel, Cisplatin - Esophageal Cancer, Chemoradiotherapy | Phase 1 / Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 105 | 2019-10-01 | 2024-12-13 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ PD-1 - PD-1, Chemoradiotherapy | Phase 1 / Phase 2 | Unknown | Peking University | 45 | 2019-08-26 | 2019-08-20 |
| A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients SZKJT(San-Zhong-Kui-Jian-Tang) - Head and Neck Neoplasm, Chemoradiotherapy | Phase 1 | Completed | China Medical University Hospital | 21 | 2018-07-07 | 2022-10-26 |
Esophageal Neoplasms (1) · Head and Neck Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Cisplatin (1) · Platinum (1) · Radiotherapy (1) · toripalimab (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · China Medical University Hospital (1) · Peking University (1)
China (1) · Taiwan (1)
Ming-Yu Lien, Ph.D (1) · Xin Wang, MD (1) · Yongheng Li, MD (1) · Ziyu Li, MD (1)